Printer Friendly
The Free Library
19,595,263 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

CancerVax Presents at BIO CEO & Investor Conference; Presentation to be Webcast On Company's Corporate Web Site.


Business Editors/Medical Writers

CARLSBAD, Calif. & NEW YORK--(BUSINESS WIRE)--Feb. 20, 2002

CancerVax(TM) Corporation announced today that President and Chief Executive Officer David Hale will present an overview of the Company on Thursday, February 21 at 2:00 p.m. (EST EST electroshock therapy.

EST
abbr.
electroshock therapy
) during the BIO CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  & Investor Conference (BIO CEO). The presentation will be accessible online live and archived in CancerVax's corporate web site, www.cancervax.com.

The BIO CEO & Investor Conference, sponsored by the Biotechnology Industry Organization Biotechnology Industry Organization or BIO was founded 1993 in Washington, DC. James C. Greenwood is BIO's current President. External links
  • BIO Website
, is an annual forum in which select public and privately held biotechnology companies may present their advances to potential investors and partners. This year's conference, "Investing in Biotechnology: The Value, The Risks, The Rewards", is being held February 20-22 at the Waldorf Astoria in New York City New York City: see New York, city.
New York City

City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S.
.

CancerVax Corporation is a privately held biotechnology company dedicated to the discovery, development and commercialization of biological products for the treatment, prevention and control of cancer. CancerVax is conducting two international, multi-center Phase 3 clinical trials phase 3 clinical trial Phase 3 study. See Phase study.  for its Canvaxin(TM) therapeutic vaccine therapeutic vaccine Immunology A vaccine–eg, Salk's Remune intended to treat a viral infection by stimulating the immune system. See Vaccine therapy.  in the treatment of Stage III and Stage IV melanoma at more than 50 clinical trial sites around the world. CancerVax maintains its corporate and R&D headquarters in Carlsbad, California, and its biologics manufacturing facility in Los Angeles, California. For more information about CancerVax, please visit our web site at http://www.cancervax.com.

CancerVax(TM) and CANVAXIN(TM) are trademarks of CancerVax(TM) Corporation.
COPYRIGHT 2002 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2002, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 20, 2002
Words:234
Previous Article:Microtel International Adds to CXR Telecom Management Team.
Next Article:Three New Members Join Sonus Networks' Open Services Partner Alliance; 2Wire, Sage Instruments and Tainet Expand Program Offerings With...
Topics:



Related Articles
CancerVax Completes $55 Million Financing; Proceeds Used to Fund Continued Development of the CANVAXIN Vaccine and Other Technologies.
CancerVax CEO David Hale to Present at UBS Warburg Global Life Sciences Conference; Presentation Will Be Webcast On CancerVax Web Site.
CancerVax Corporation to Host Conference Call and Live Webcast to Discuss Third Quarter 2003 Financial Results.
CancerVax to Webcast Corporate Presentation at Piper Jaffray Health Care Conference.
CancerVax to Webcast Corporate Presentation at Roth Capital Partners Conference.
CancerVax to Webcast Corporate Presentation at BIO CEO & Investor Conference.
CancerVax to Webcast Corporate Presentation at Lehman Brothers Annual Global Healthcare Conference.
CancerVax to Webcast Corporate Presentation at SG Cowen Annual Healthcare Conference.
CancerVax Corporation to Host Conference Call and Live Webcast to Discuss First Quarter 2004 Financial Results.
CancerVax to Webcast Corporate Presentation at Pacific Growth Equities Life Sciences Growth Conference.

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles